logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

J&T EXPRESS-W (01519) spent 2.3108 million Hong Kong dollars to buy back 379,000 shares on November 12th.

date
19:59 12/11/2024
avatar
GMT Eight
Jitu Express-W (01519) announced on November 12, 2024 that it invested 2.31 million Hong Kong dollars...
J&T EXPRESS-W(01519) announced that on November 12, 2024, it will spend 2.3108 million Hong Kong dollars to repurchase 37,900 shares, at a repurchase price of 6.08-6.11 Hong Kong dollars per share.
Related Articles
China Stock
Guotai Haitong: Insurance and securities companies all received increased allocations, optimistic about the non-bank opportunities following the influx of residential funds into the market.
New stock news | Di Zhe Pharmaceutical (688192.SH) submits documents to the Hong Kong Stock Exchange. The two approved drugs are Shuwozhe and Gaoruizhe.
New stock news | Di Zhe Medicine (688192.SH) submits documents to the Hong Kong Stock Exchange
Guotai Haitong: Insurance and securities companies all received increased allocations, optimistic about the non-bank opportunities following the influx of residential funds into the market.
China Stock
New stock news | Di Zhe Pharmaceutical (688192.SH) submits documents to the Hong Kong Stock Exchange. The two approved drugs are Shuwozhe and Gaoruizhe.
New stock news | Di Zhe Medicine (688192.SH) submits documents to the Hong Kong Stock Exchange
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
icon
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
icon
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
icon
22/01/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.